The efficacy of mindfulness-based cognitive therapy in recurrent depressed patients with and without a current depressive episode: a randomized controlled trial by Aalderen, J.R. van et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/92456
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
The eﬃcacy of mindfulness-based cognitive therapy
in recurrent depressed patients with and without
a current depressive episode: a randomized
controlled trial
J. R. van Aalderen*, A. R. T. Donders, F. Giommi, P. Spinhoven, H. P. Barendregt
and A. E. M. Speckens
Department of Psychiatry, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Background. The aim of this study is to examine the eﬃcacy of mindfulness-based cognitive therapy (MBCT)
in addition to treatment as usual (TAU) for recurrent depressive patients with and without a current depressive
episode.
Method. A randomized, controlled trial comparing MBCT+TAU (n=102) with TAU alone (n=103). The study
population consisted of patients with three or more previous depressive episodes. Primary outcome measure was
post-treatment depressive symptoms according to the Hamilton Rating Scale for Depression. Secondary outcome
measures included the Beck Depression Inventory, rumination, worry and mindfulness skills. Group comparisons
were carried out with linear mixed modelling, controlling for intra-group correlations. Additional mediation analyses
were performed. Comparisons were made between patients with and without a current depressive episode.
Results. Patients in the MBCT+TAU group reported less depressive symptoms, worry and rumination and
increased levels of mindfulness skills compared with patients receiving TAU alone. MBCT resulted in a comparable
reduction of depressive symptoms for patients with and without a current depressive episode. Additional analyses
suggest that the reduction of depressive symptoms was mediated by decreased levels of rumination and worry.
Conclusions. The study ﬁndings suggest that MBCT is as eﬀective for patients with recurrent depression who are
currently depressed as for patients who are in remission. Directions towards a better understanding of the
mechanisms of action of MBCT are given, although future research is needed to support these hypotheses.
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Introduction
Major depression is serious health problem. Its life-
time prevalence is 16.2% and the 12-month prevalence
is 6.6% (Kessler et al. 2003). The probability of relapse
increases with every depressive episode (Eaton et al.
2008).Consequently, thedevelopment of eﬀective strat-
egies to prevent relapse is very important. The usual
treatment oﬀered is antidepressant medication, which
often yields unwanted side eﬀects, compromising
patient compliance (Hollon et al. 2002, 2005).
Mindfulness-based cognitive therapy (MBCT) is
an alternative, psychological intervention designed
for prevention of relapse in recurrent depression. It
is a group-based, 8-week training (Segal et al. 2002),
consisting of meditation exercises combined with
cognitive behavioural techniques. Mindfulness-based
approaches have been successfully applied to a broad
range of health and stress-related problems (Kabat-
Zinn et al. 1992 ; Hofmann et al. 2010). In patients with
three or more previous depressive episodes, Teasdale
et al. (2000) showed that MBCT resulted in a 40%
relapse rate in the year following the intervention
compared with 66% in the treatment as usual (TAU)
condition (intention to treat analysis). These results
were replicated in a second study (Ma & Teasdale,
2004). In contrast with the above-mentioned studies,
Bondolﬁ et al. (2010) did not show MBCT to be su-
perior to TAU alone for patients with recurrent de-
pression. Explanations oﬀered for this discrepancy are
the possible diﬀerences in the standard of TAU or the
* Address for correspondence : J. R. van Aalderen, Department of
Psychiatry, Radboud University Nijmegen Medical Centre,
Reinier Postlaan 10, 6500 HB Nijmegen, The Netherlands.
(Email : J.vanaalderen@psy.umcn.nl)
Psychological Medicine (2012), 42, 989–1001. f Cambridge University Press 2011
doi:10.1017/S0033291711002054
ORIGINAL ARTICLE
level of experience of the MBCT trainers. Kuyken et al.
(2008) showed that MBCT was as eﬀective as mainten-
ance antidepressant medication (m-ADM) in prevent-
ing relapse in patients with three or more previous
depressive episodes (Kuyken et al. 2008). Patients re-
ceiving MBCT reported less depressive symptoms and
higher quality of life. This ﬁnding of MBCT being
equally eﬀective as m-ADM was recently conﬁrmed
by Segal et al. (2010) in a trial showing equal reduction
in relapse risk for m-ADM and MBCT; however, only
in unstable remitters.
In addition to preventing relapse of depression,
several preliminary, mostly uncontrolled studies have
shown MBCT to be eﬃcacious in reducing depressive
symptoms per se (Finucane & Mercer, 2006; Kenny &
Williams, 2007 ; Kingston et al. 2007 ; Eisendrath et al.
2008 ; Barnhofer et al. 2009). This research extends the
founding inception of MBCT, namely, that the pro-
gramme was developed with the purpose of prevent-
ing remission of depression and considered unsuitable
for acute depression. Symptoms such as diﬃculty with
concentration and intensity of negative thinking were
hypothesized to preclude the acquisition of attention
control skills central to the training (Segal et al. 2002).
For this reason, patients with recurrent depression not
in remission were indeed excluded from previous
studies (Teasdale et al. 2000 ; Ma & Teasdale, 2004).
The aim of this study was to examine the eﬃcacy of
MBCT in a more representative sample of patients
with recurrent depression, including those using an-
tidepressant medication or with previous cognitive
behavioural therapy or meditation experience. We
also wanted to examine whether MBCT was eﬀective
for patients with or without a current depressive epi-
sode. Finally, we wanted to investigate rumination,
worry andmindfulness skills as possible mediators for
the reduction of depressive symptoms in the MBCT
condition. We expected increased mindfulness skills,
such as ‘act with awareness ’, would increase insight
into the patients’ own maladaptive cognitive, aﬀective
and behavioural processes, reducing the likelihood of
repeated depressive episodes (Teasdale et al. 1995).
Method
Design
A randomized, controlled design was used comparing
MBCT plus TAU with TAU alone. Patients in the TAU
condition participated in the MBCT training after a
3-month waiting list period. In order to investigate
the stability of the eﬀects of MBCT, patients in both
conditions were followed for 1 year after completing
MBCT. The results at 1-year follow-up will be pre-
sented separately.
As the studies of Teasdale et al. (2000) and Ma
& Teasdale (2004) only included patients with a
Hamilton Rating Scale for Depression (HAMD;
Hamilton, 1960) score of <10, randomization of the
current trial was stratiﬁed according to a HAMD score
<10 or o10. Block-randomization was used, with
block size of 12 for HAMD <10 and block size of
four for HAMD o10. A list of random numbers
was generated for both groups. Assignment to groups
was conducted by an independent researcher.
Participants
The study population consisted of patients with three
or more previous depressive episodes according to
DSM-IV criteria. Patients using antidepressant medi-
cation were required to be on a stable dose for at least
6 weeks and were asked to maintain this dosage for
the study period. Exclusion criteria for the study were:
(1) one or more previous (hypo)manic episodes ac-
cording to DSM-IV criteria ; (2) current alcohol and/or
drug abuse ; (3) urgent need for psychiatric treatment,
for example, suicidality or psychotic symptoms; (4)
problems impeding participating in a group, such as
severe borderline personality disorder ; (5) problems
impeding completing the questionnaires, such as cog-
nitive dysfunctions.
Procedure
Patients were referred by their general practitioners
or psychiatrists and psychologists in and around the
city of Nijmegen. Alternatively, they were self-
referred, informed by local and national advertise-
ments. Patients were then screened by telephone and,
if applicable, invited for a research interview includ-
ing the Mini-International Neuropsychiatric Interview
(MINI) (Sheehan et al. 1998 ; van Vliet et al. 2000), in-
cluding the section on recurrent depression according
to the Structural Clinical Interview for DSM-IV Axis I
Disorders (First et al. 1995 ; Groenestijn et al. 1999). The
interviews were used to conﬁrm inclusion and ex-
clusion criteria and were conducted by a psychologist
or psychiatrist in training, supervised by an experi-
enced psychiatrist.
For the MBCT condition, questionnaires were ad-
ministered at the time of the research interview and
after the last MBCT session. For the TAU condition,
questionnaires were administered at the time of the re-
search interview and before their ﬁrst MBCT session.
After completing MBCT, all patients were reassessed
at 3, 6, 9 and 12 months follow-up.
The study was approved by the Medical Ethical
Committee of local hospitals in Nijmegen, the
Netherlands. After complete description of the study
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to the subjects, written informed consent was ob-
tained.
Mindfulness-based cognitive therapy
MBCT was delivered according to the guidelines of
Segal et al. (2002). Training consisted of eight weekly
sessions of 2.5 h and a silent day of 6 h meditation. In
addition to the group sessions, participants were in-
structed to practise 6 days per week for approximately
45 min per day. Compliance was assessed by attend-
ance and weekly homework diaries. To support home
practice, patients received CDs with guided medi-
tations and exercises. Group size varied between eight
and 14 participants. After completing MBCT, par-
ticipants were invited to attend monthly 1-h booster
sessions and silent days of consecutive MBCT groups.
Three diﬀerent MBCT instructors participated in
the study: (1) a psychiatrist and cognitive behavioural
therapist ; (2) a clinical psychologist ; (3) an occu-
pational therapist. All had received at least 1.5 years of
training in MBCT and were experienced in working
with patients with a wide range of psychiatric prob-
lems and groups. Trainers were also experienced
meditators, with meditation practice ranging between
2 and 20+ years.
Measures
As a primary outcome measure, HAMD was used.
The HAMD is a standardized 17-item interview to
measure number and severity of depressive symp-
toms on a 0–52 score range (Hamilton, 1960 ; Bech et al.
1989). The HAMD has good psychometric properties
(Morriss et al. 2008).
In addition, the following questionnaires were ad-
ministered:
1. Beck Depression Inventory (BDI), a 21-item self-
report questionnaire to measure depressive symp-
toms, score range 0–63 (Beck et al. 1961 ; Bouman
et al. 1985). The BDI has shown good psychometric
properties (Beck et al. 1988).
2. Rumination on Sadness Scale (Dutch translation), a
13-item, 5-point scale, self-report questionnaire de-
signed to measure ruminative thought, (imagining)
when one feels ‘sad, down or depressed’ (Raes et al.
2003).
3. Penn State Worry Questionnaire, a 16-item, 5-point
scale, self-report questionnaire, designed to meas-
ure the concept of worry (Meyer et al. 1990 ; van
Rijsoort et al. 1999).
4. Kentucky Inventory of Mindfulness (KIMS) is a
39-item, 5-point scale self-report questionnaire,
developed to measure the level of proﬁciency in
diﬀerent mindfulness skills (Baer et al. 2004, 2006).
It covers four domains : observe ; describe ; act with
awareness ; accept without judgement. Recently, it
has been shown that the KIMS has good psycho-
metric properties for clinical samples (Baum et al.
2010).
5. The World Health Organization Quality of Life,
self-report questionnaire, constructed to measure
subjective experienced quality of life (de Vries &
van Heck, 1996). This version is a 26-item, 5-point
scale covering four domains : physical ; psychologi-
cal ; social ; environment. Only the ﬁrst three do-
mains are presented.
Statistical analysis
All analyses were carried out using the intention
to treat sample. As <3% of the data was missing, re-
ported results are based on complete data. Sensitivity
analysis based on worse case imputation revealed no
diﬀerence in direction nor signiﬁcance for all out-
comes.
Post-measurement scores were compared between
the two groups, controlling for baseline depression
levels. Additional analyses were performed within
subgroups with and without a current depressive
episode. To account for possible diﬀerences between
therapy groups, we added a random group eﬀect. All
analyses were performed using linear mixed models
including an exploratory moderation analyses. A
Cohen’s d eﬀect size was calculated based on the
complete group (n=205) baseline standard deviation
to avoid a contamination of standard deviation due to
therapy eﬀects.
Additional information about reliable change for
the HAMD scores is provided, calculated and visually
presented based on the work of Jacobson & Truax,
(1991), using test–retest reliability to correct for
measurement errors of the HAMD, again using the
complete group baseline standard deviation.
For the mediation analysis, we followed the re-
commendations of Preachers and Hayes for multiple
mediation models (Preacher & Hayes, 2008). In all
mediation analyses, HAMD post-measurement scores
were controlled for baseline depression by using pre-
measurement HAMD scores as a covariate. Residual
change scores for all potential mediators were calcu-
lated (MacKinnon, 2008). To explore whether the
mediators (partly) eﬀected the relation of condition on
post-treatment depression levels, the model including
the potential mediators was compared with the model
without mediators for both univariate and multi-
variate models. An advantage of a multivariate model
over several univariate models is the possibility of
determining the relative contribution of each indirect
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eﬀect in relation with the other mediators (Preacher &
Hayes, 2008). Subsequently, 95% bias corrected and
accelerated conﬁdence intervals (95% CI) were calcu-
lated to explore the contribution of each individual
mediator and the group of mediators in total. SPSS
macro command sets for indirect mediation were
downloaded from http://www.comm.ohio-state.edu/
ahayes. SPSS package 17.0 and R 2.9.1 (R Development
Core Team, 2009) were used for analyses and graphs.
Results
Study population
Of the 258 patients interviewed, 33 were excluded and
six refused to participate. Reasons for exclusion were:
(1) not having three or more previous depressive
episodes (n=19) ; (2) change in medication within 6
weeks before the start of the study (n=4) ; (3) previous
(hypo)manic episodes (n=2) ; (4) current substance
abuse (n=3) ; (5) acute need of psychiatric treatment
(n=2) ; (6) problems to participate in a group therapy
(n=2) ; (7) cognitive impairments (n=1).
A total number of 219 patients were included
and eventually 205 patients were analysed (MBCT
n=102; TAU n=103), see Fig. 1 for a detailed de-
scription of the patient ﬂow. Within each condition,
the groups were divided into subgroups with and
without a major depressive episode based on theMINI
interview. As a result of incomplete or missing MINI
interviews, for 20 patients the diagnosis of current
depression was based on the available clinical infor-
mation. For four patients it was impossible to do
so and they were excluded from the study. Another
10 patients were excluded from analysis due to one or
more other missing critical values.
There were no baseline diﬀerences between the
groups with regard to age [MBCT: mean=47.3 (S.D.=
11.5) years ; TAU: mean=47.7 years (S.D.=11.1)] or
other sociodemographic or clinical characteristics
(see Table 1).
The mean number of depressive episodes for the
complete sample was 7.4 (S.D.=7.0, modal number of
episodes=3) with no diﬀerences between the MBCT
and TAU conditions, t(195)=x0.61, p=0.54. Mean
age at onset of the ﬁrst depressive episode was 23.8
years (S.D.=11.2, modal age of onset=20 years), with a
slightly higher age of onset in the MBCT than in the
TAU condition [MBCT, t(195)=x1.98, p<0.05]. When
taking the three most severe depressive episodes into
account, the mean time between the last episode and
the start of the study for the non-depressed patients
was 28 months (S.D.=48.0, median=8 months).
During MBCT, nine patients (8.8%) dropped out
(less than four sessions MBCT), for the following rea-
sons : training elsewhere ; terminal disease ; care for
sick mother ; increasing tension (three) ; social phobia ;
for practical reasons (two).
Allocation Allocated to TAU (n = 108)Allocated to MBCT (n = 111)
AnalysisAnalysed (ITT sample: n = 102)
Excluded from analysis (n = 9)
Reason for exclusion: one or more
critical missing values
Dropout ( <4 sessions) (n = 9)
Reasons for dropout: training
elsewhere; terminal disease; care for
disease mother; increasing tension (3);
social phobia; practical reasons (2)
Analysed (ITT sample: n = 103)
Excluded from analysis (n = 5)
Reason for exclusion: one or more
critical missing values
Assessed for eligibility (n = 258)
Enrolment
Not meeting inclusion criteria (n = 33)
Refused to particpate (n = 6)
Randomization
(n = 219)
Fig. 1. CONSORT ﬂow diagram.
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Table 1. Baseline characteristics of mindfulness-based cognitive therapy (MBCT) and treatment as usual (TAU) conditions for the total group of participants and the two subgroups without and with a
current depressive episode
Baseline characteristics ; n (%)
Total group No current depression Currently depressed
MBCT
(n=102)
TAU
(n=103) Sig.b
MBCT
(n=68)
TAU
(n=68) Sig.b
MBCT
(n=34)
TAU
(n=35) Sig.b
Female 71 (70) 74 (72) p=0.73 48 (71) 52 (77) p=0.56 23 (68) 22 (63) p=0.68
Married/Cohabiting 66 (64) 66 (64) p=0.57 19 (59) 44 (68) p=0.61 22 (65) 22 (71) p=0.67
Care for children 43 (42) 36 (35) p=0.40 28 (43) 23 (35) p=0.37 13 (42) 15 (44) p=0.86
Employed 52 (51) 51 (50) p=0.66 34 (52) 41 (64) p=0.37 18 (53) 10 (32) p=0.29
Tertiary education 67 (66) 55 (53) p=0.44 45 (68) 39 (60) p=0.79 22 (34) 16 (52) p=0.37
Antidepressant medication 53 (52) 48 (47) p=0.62 35 (57) 32 (53) p=0.59 18 (58) 16 (57) p=0.94
Previous cognitive behavioural therapy 61 (60) 58 (56) p=0.56 45 (71) 40 (65) p=0.41 18 (67) 16 (64) p=0.84
Recent meditation experiencea 49 (48) 48 (47) p=0.94 33 (50) 30 (46) p=0.66 16 (49) 18 (55) p=0.62
Symptoms at baseline ; mean (S.D.) Sig.c Sig.c Sig.c
Depression (HAMD) 9.5 (6.2) 9.2 (5.6) p=0.79 8.0 (5.7) 7.8 (6.3) p=0.81 12.4 (6.3) 12.1 (6.4) p=0.83
Depression (BDI) 14.9 (9.2) 16.2 (9.4) p=0.30 11.9 (7.3) 13.8 (7.6) p=0.15 20.7 (9.8) 21.3 (10.8) p=0.81
Rumination (RSS) 28.0 (9.5) 28.4 (9.6) p=0.74 27.2 (9.9) 28.3 (9.5) p=0.52 29.4 (8.7) 28.7 (10.0) p=0.76
Worry (PSWQ) 42.6 (12.3) 43.7 (11.5) p=0.50 39.6 (12.7) 43.0 (11.9) p=0.10 48.6 (9.1) 45.2 (12.4) p=0.21
Mindfulness skills (KIMS)
Observe 19.0 (7.5) 18.7 (7.4) p=0.76 19.3 (7.2) 18.0 (6.9) p=0.31 18.6 (8.0) 20.1 (8.2) p=0.44
Describe 18.4 (8.2) 18.3 (7.8) p=0.91 19.7 (7.3) 18.7 (7.4) p=0.45 15.9 (9.5) 8.6 (17.4) p=0.50
Act with awareness 15.9 (6.1) 16.8 (5.6) p=0.31 16.7 (5.8) 17.4 (5.6) p=0.51 14.4 (6.4) 15.6 (5.7) p=0.43
Accept without judgement 18.4 (6.2) 18.0 (6.4) p=0.63 19.2 (6.5) 19.0 (6.3) p=0.86 16.8 (5.5) 15.8 (6.0) p=0.49
Quality of Life (WHOQOL-Bref)d
Physical 22.0 (5.5) 20.8 (4.9) p=0.14 23.7 (5.4) 22.1 (4.5) p=0.09 18.8 (4.2) 18.1 (4.6) p=0.56
Psychological 18.2 (3.5) 18.2 (3.4) p=0.99 18.9 (3.3) 18.0 (3.1) p=0.94 16.6 (3.3) 16.5 (3.5) p=0.92
Social 9.7 (2.3) 10.3 (2.2) p=0.12 9.7 (1.9) 10.4 (2.0) p=0.05 9.7 (1.9) 9.8 (2.7) p=0.88
HAMD, Hamilton Rating Scale for Depression ; BDI, Beck Depression Inventory ; RSS, Rumination on Sadness Scale ; PSWQ, Penn State Worry Questionnaire ; KIMS, Kentucky
Inventory of Mindfulness ; WHOQOL-Bref, World Health Organization Quality of Life, self-report questionnaire.
aMeditation and/or body focused experience<6 months ago.
b x2 tests.
c Independent sample t tests.
dMeasured in a subsample : MBCT [n=89 (non-depressed, n=59 ; depressed, n=30)] ; TAU [n=74 (non-depressed, n=51 ; depressed, n=23)].
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A subsample of the MBCT group (n=94) was asked
to ﬁll out homework diaries during the training, of
whom 77 (82%) patients handed them in. The average
number of days patients practised was 30 (S.D.=10.2 ;
range 0–42 days). A modest correlation was found
between formal practice (e.g. sitting meditation) and
change of depression level during MBCT, r=0.26,
p<0.05.
The period between baseline and end of treatment/
waitlist assessment was signiﬁcantly longer in the
TAU [mean=83 days (S.D.=33.9)] than in the MBCT
[mean=59 days (S.D.=12.9) ; t(175)=6.4, p<0.01)]
condition.
Eﬃcacy of MBCT
Depressive symptoms
At the end of the treatment/waiting period, patients in
the MBCT condition had signiﬁcantly less depressive
symptoms than those in the TAU condition according
to both HAMD [F(1, 202)=15.9, p<0.001] and BDI
[F(1, 44.8)=20.9, p<0.001] (see Table 2). Controlling
for baseline scores did not result in a change of dif-
ferences between the intervention and control groups.
Adding a random eﬀect for the diﬀerent therapy
groups did not result in changes of outcome for any of
the models.
Exploratory moderation analyses were carried out
for the complete sample with a selection of baseline
variables : number of depressions ; age of onset of the
ﬁrst depression; all baseline variables listed in Table 1
except quality of life. Only previous meditation
experience in the last 6 months prior to the study sig-
niﬁcantly moderated post-measurement levels of de-
pression [F(1, 192.0)=6.92, p<0.01]. Within the MBCT
condition, patients without meditation experience
showed lower end of treatment levels of depression
compared with patients with recent meditation ex-
perience [F(1, 96)=4.29, p<0.05].
Rumination, worry and mindfulness skills
End of treatment/waiting period levels of rumination
and worry were signiﬁcantly lower in the MBCT con-
dition than in the TAU condition [F(1, 44.3)=13.4,
p<0.01 and F(1, 83.2)=17.5, p<0.001, respectively].
Both showed a moderate eﬀect size (see Table 2).
Moreover, all mindfulness skills showed signiﬁcant in-
creased levels : observe [F(1, 49.8)=27.7, p<0.001] ; act
with awareness [F(1, 47.4)=39.5 p<0.001] ; describe
Table 2. Depressive symptoms, rumination, mindfulness skills and quality of life at post-treatment of mindfulness-based cognitive
therapy (MBCT) and treatment as usual (TAU) conditions, controlling for baseline levels of symptoms
Post-measurement results ;
mean (S.D.)a
Total group
MBCT
(n=102)
TAU
(n=103)
Group diﬀerence
(95% CI)b Cohen’s d
Depression (HAMD) 7.5 (5.8) 10.5 (6.8) x3.1 (x4.6 tox1.6)d 0.53
Depression (BDI) 10.3 (7.8) 16.2 (9.8) x4.6 (x6.6 tox2.6)d 0.50
Rumination (RSS) 22.0 (8.6) 27.3 (10.6) x4.8 (x7.4 tox2.2)d 0.50
Worry (PSWQ) 36.8 (12.0) 42.5 (10.7) x5.1 (x7.6 tox2.7)d 0.43
Mindfulness skills (KIMS)
Observe 22.8 (7.4) 18.2 (7.1) 4.8 (3.0 to 6.7)d 0.65
Describe 19.7 (7.6) 17.9 (7.2) 1.6 (0.3 to 2.8)d 0.20
Act with awareness 20.0 (5.6) 16.1 (6.0) 4.3 (3.0 to 5.7)d 0.74
Accept without judgement 22.3 (5.5) 18.6 (6.7) 3.2 (1.9 to 4.5)d 0.51
Quality of Life (WHOQOL-Bref)d
Physical 23.6 (5.3) 21.6 (5.1) 1.0 (x0.2 to 2.2) 0.19
Psychological 19.9 (3.4) 18.4 (3.7) 1.2 (0.4 to 2.1)d 0.36
Social 10.2 (2.1) 10.0 (2.3) 0.3 (x0.3 to 0.8) 0.13
HAMD, Hamilton Rating Scale for Depression ; BDI, Beck Depression Inventory ; RSS, Rumination on Sadness Scale ; PSWQ,
Penn State Worry Questionnaire ; KIMS, Kentucky Inventory of Mindfulness ; WHOQOL-Bref, World Health Organization
Quality of Life, self-report questionnaire.
a Unadjusted condition means and standard deviations (S.D.).
b Diﬀerences between conditions, corrected for baseline values.
cMeasured in a subsample : MBCT [n=89 (non-depressed, n=59 ; depressed, n=30)] ; TAU [n=74 (non-depressed, n=51 ;
depressed, n=23)].
d Statistical signiﬁcant diﬀerence for p<0.05.
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Table 3. Depressive symptoms, rumination, mindfulness skills and quality of life at post-treatment of mindfulness-based cognitive therapy (MBCT) and treatment as usual condition (TAU),
controlling for baseline levels of symptoms, for both subgroups without and with a current depressive episode respectively
Post-measurement results ;
mean (S.D.)a
No current depression Currently depressed
MBCT
(n=68)
TAU
(n=68)
Group diﬀerence
(95% CI)b Cohen’s d
MBCT
(n=34)
TAU
(n=35)
Group diﬀerence
(95% CI)b Cohen’s d
Depression (HAMD) 6.2 (4.7) 9.1 (5.6) x2.9 (x4.6 tox1.3)d 0.58 10.2 (6.7) 13.4 (8.1) x3.3 (x6.6 tox0.1)d 0.53
Depression (BDI) 8.6 (6.3) 14.0 (8.0) x4.2 (x6.2 tox2.2)d 0.56 13.7 (9.5) 20.4 (11.7) x5.3 (x10.0 tox0.6)d 0.53
Rumination (RSS) 21.3 (8.6) 26.4 (10.4) x4.4 (x7.6 tox1.3)d 0.46 23.4 (8.6) 29.2 (10.9) x5.4 (x9.5 tox1.3)d 0.59
Worry (PSWQ) 34.6 (11.3) 41.6 (10.2) x5.4 (x8.2 tox2.5)d 0.45 41.1 (12.5) 44.4 (11.5) x4.8 (x9.8 to 0.1)d 0.49
Mindfulness skills (KIMS)
Observe 22.8 (7.4) 17.8 (7.1) 4.4 (2.3 to 6.5)d 0.62 22.9 (7.5) 19.0 (7.1) 5.2 (1.7 to 8.6)d 0.64
Describe 20.4 (7.1) 18.2 (7.0) 1.4 (0.0 to 2.7) 0.19 18.3 (8.5) 17.5 (7.7) 1.8 (x0.5 to 4.2) 0.20
Act with awareness 20.7 (5.4) 16.7 (5.6) 4.3 (2.6 to 6.1)d 0.77 18.7 (6.0) 15.0 (6.8) 4.5 (1.9 to 7.2)d 0.74
Accept without judgement 23.2 (5.4) 16.7 (5.6) 3.5 (1.9 to 5.1)d 0.52 20.4 (4.8) 16.9 (7.1) 2.8 (0.4 to 5.2)d 0.49
Quality of Life (WHOQOL-Bref)c
Physical 25.0 (4.8) 22.5 (4.7) 1.2 (x0.3 to 2.7) 0.23 20.6 (5.3) 19.7 (5.3) 1.0 (x1.4 to 3.4) 0.22
Psychological 20.2 (3.3) 18.9 (3.3) 1.1 (0.1 to 2.1)d 0.33 19.2 (3.5) 17.3 (4.2) 1.5 (0.1 to 3.0)d 0.46
Social 10.2 (2.2) 10.3 (2.1) 0.2 (x0.5 to 0.9) 0.01 10.1 (2.0) 9.5 (2.6) 0.5 (x0.5 to 1.4) 0.17
HAMD, Hamilton Rating Scale for Depression ; BDI, Beck Depression Inventory ; RSS, Rumination on Sadness Scale ; PSWQ, Penn State Worry Questionnaire ; KIMS, Kentucky
Inventory of Mindfulness ; WHOQOL-Bref, World Health Organization Quality of Life, self-report questionnaire.
a Unadjusted condition means and standard deviations (S.D.).
b Diﬀerences between conditions, corrected for baseline values.
cMeasured in a subsample : MBCT [n=89 (non-depressed, n=59 ; depressed, n=30)] ; TAU [n=74 (non-depressed, n=51 ; depressed, n=23)].
d Statistical signiﬁcant diﬀerence (p<0.05).
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[F(1, 49.0)=6.6, p<0.05] ; accept without judgement
[F(1, 192.0)=22.9, p<0.001]. Except for describe, all
domains showed moderate to large eﬀect sizes (see
Table 2).
Of the quality of life scores, only the psychologi-
cal domain showed a signiﬁcant increase in the
MBCT condition compared with the TAU condition
[F(1, 153)=9.2, p<0.01].
Diﬀerences between patients with and without a current
depressive episode
Split-ﬁle analyses for patients with and without a
current depressive episode showed overall compar-
able results with the complete sample analysis (see
Table 3). Rumination and the mindfulness subscale
‘describe ’ did not diﬀer signiﬁcantly within the group
without a current depressive episode in contrast with
the group having a current episode. Also, psychologi-
cal improvement of quality of life was only signiﬁ-
cantly diﬀerent in the depressed group. Cohen’s d
eﬀect sizes were comparable with the complete sample
eﬀect sizes. The depression-related variables ‘rumi-
nation’ and ‘worry’ showed even higher eﬀect sizes in
the subgroup analyses, possibly due to smaller stan-
dard deviations.
To further investigate whether depressive symp-
toms at baseline inﬂuenced the eﬃcacy of MBCT, we
performed an interaction analysis adding an interac-
tion term between baseline depression levels (HAMD)
and condition. We found no signiﬁcant interaction
for any of the outcome variables, indicating that the
eﬃcacy of MBCT is independent of baseline level of
depression. Using split-ﬁle analyses for patients with
and without a current depressive episode, no signiﬁ-
cant interactions were found between baseline
depression levels (HAMD) and any of the outcome
measures. The result for the interaction analysis be-
tween baseline depression levels and end of treatment
levels of depression (HAMD) is graphically presented
in Fig. 2, showing baseline and end of treatment levels
of depression in both conditions. From this ﬁgure it
becomes apparent that the reduction of depressive
symptoms as a result of MBCT is independent from
the baseline level of depression.
Clinically signiﬁcant change
A clinically signiﬁcant change of the HAMD scores,
the primary outcome measure, is presented in Table 4,
using both the Jacobson–Truax reliable change index
and the absolute cut-oﬀ level of HAMD 10 as criteria
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Fig. 2. Interaction plot for pre- and post-measurement depression levels [Hamilton Rating Scale for Depression (HAMD) scores]
of Mindfulness-based Cognitive Therapy (MBCT) and treatment as usual (TAU) condition. The short vertical lines
depicted on the x-axis represent the distribution of pre-measurement depression scores (HAMD; range 0–25). Note that
independent of the pre-measurement level of depression, the post-measurement depression score diﬀerence between the MBCT
and TAU condition is constant (for example ‘a ’=‘b ’).
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(Jacobson & Truax, 1991), also illustrated in Fig. 3.
If improvement is deﬁned by a HAMD score <10
and having a reliable positive change in depression
scores, Table 4 illustrates that, in the MBCT condition,
patients more frequently improved than in the TAU
condition (15 v. 8). It also demonstrates that more
patients in the TAU condition deteriorate than in
the MBCT condition (5 v. 18). Overall, the MBCT con-
dition signiﬁcantly diﬀers from the TAU condition
in terms of individual change scores [x2(3)=9.69,
p<0.05].
Mediation analysis
Rumination, worry and the four separate mindfulness
skills were expected to be mediators between the
MBCT training and post-measurement levels of de-
pression (HAMD). Predicted mediators were ﬁrst
analysed using a univariate model and, if shown to be
a contributing factor, were entered into a multivariate
model.
The main analyses revealed that all the suggested
mediators were related to condition (MBCT versus
Table 4. Numbers and percentages of depression change based on the Jacobson–Truax Reliable Change Index (RCI), calculated for
HAMD scores, pre- and post-measurement of the MBCT and TAU conditions, stratiﬁed for amount of depressive symptoms, also
displayed in Fig. 3
Depression diagnosis
at baseline
Improved (.) Changed (,) Not changed (#) Deteriorated (+)
Past cut-oﬀ + + x +
RCI criterion + x x +
No current depression, n (%) MBCT (n=68) 10 (14.7) 3 (4.4) 52 (76.5) 3 (4.4)
TAU (n=68) 4 (5.9) 2 (2.9) 50 (73.5) 12 (17.6)
Current depression, n (%) MBCT (n=34) 5 (14.7) 2 (5.9) 25 (73.5) 2 (5.9)
TAU (n=35) 4 (11.4) 2 (5.7) 23 (65.7) 6 (17.1)
Total, n (%) MBCT (n=102) 15 (14.7) 5 (4.9) 77 (75.5) 5 (4.9)
TAU (n=103) 8 (7.8) 4 (3.9) 73 (70.9) 18 (17.5)
HAMD, Hamilton Rating Scale of Depression ; MBCT, mindfulness-based cognitive therapy ; TAU, treatment as usual.
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Fig. 3. Change in depression scores between pre- and post-measurement based on Hamilton Rating Scale for Depression
(HAMD) scores for treatment as usual (TAU) and mindfulness-based cognitive therapy (MBCT) conditions. The diagonal line
represents ‘no pre-post measurement HAMD change ’ and the dashed upper and lower lines represent the bounds of
the 95% CI of the Jacobson–Truax Reliable Change Index. The horizontal and vertical grey lines represent the HAMD
cut-oﬀ score of 10. Improvement is deﬁned as a pre-HAMD score>10 and a post-HAMD score<10 combined with
meeting the criterion for reliable change. See Table 3 for accompanying numbers and percentages. (Figure inspired by Evans
et al. 1998.)
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TAU). However, post-measurement depression level
was only related to rumination [b=1.46, t(192)=3.64,
p<0.001], worry [b=1.68, t(196)=4.31, p<0.001] and
the mindfulness skill ‘accept without judgement’
[b=x1.18, t(194)=x2.85, p<0.01]. The relationship
between condition and post-measurement levels of
depressions, without a mediator, yielded b=x2.81,
t(192)=x3.58, p<0.001. Adding the mediators in
three separate analyses showed a partial mediation
eﬀect for all, meaning smaller b’s and still signiﬁcant
but larger p values compared to the model without
the mediator : rumination [b=x2.00, t(192)=x2.53,
p<0.05], worry [b=x2.00, t(196)=x2.60, p<0.01]
and the mindfulness skill ‘accept without judgement’
[b=x2.20, t(194)=x2.68, p<0.01].
Bootstrapping the indirect eﬀect of condition on
post-treatment level of depression with 5000 samples
showed signiﬁcant indirect eﬀects for the mediators in
the three univariate models : rumination (point esti-
mate=x0.85, 95% CI x1.66 to x0.36) ; worry (point
estimate=x0.94 ; 95% CI x1.68 to x0.41) ; ‘accept
without judgement’ (point estimate=x0.74 ; 95% CI
x1.48 tox0.20).
With the multivariate model, after including rumi-
nation, worry and mindfulness skill ‘accept without
judgement ’, the relationship between condition and
post-measurement level of depression was no longer
signiﬁcant [b=x1.41, t(190)=x1.76, p=0.08]. Boot-
strapping showed that the total indirect eﬀect of all
mediators together was signiﬁcant (point estimate=
x1.40, 95% CI x2.30 to x0.69). Rumination (point
estimate=x0.54, 95% CI x1.30 to x0.06) and worry
(point estimate=x0.77, 95% CI x1.42 to x0.27)
made independent and signiﬁcant contributions to the
mediation relationship between condition and post-
measurement levels of depression. Mindfulness skill
‘accept without judgement’ did not make such an in-
dividual contribution (point estimate=x0.09, 95% CI
x0.69 to 0.49). The indirect eﬀect of ‘accept without
judgement ’ did not signiﬁcantly diﬀer from the in-
direct eﬀects of worry and rumination, respectively.
Exploring relationships between the diﬀerent
mediators showed that both rumination (r=x0.56,
p<0.001) and worry (r=x0.47, p<0.001) were nega-
tively correlated with ‘accept without judgement’.
The same analyses for the subgroups with and
without a current depressive episode showed com-
parable direction of the outcomes, but mostly non-
signiﬁcant results due to small sample sizes.
Discussion
This study shows that, for patients with three or more
previous depressive episodes, MBCT results in a de-
crease of depressive symptoms, worry and rumination
and improvement in mindfulness skills. Most im-
portantly, we found no diﬀerences between patients
with and without a current depressive episode in
terms of reduction of depressive symptoms. The
amount of formal practice seems to have some relation
with decrease in depressive symptoms. The results
suggest that post-measurement levels of depressive
symptoms were mediated by a decrease in worry and
rumination.
This study presents the ﬁrst large-scale, ran-
domized, controlled study showing MBCT to be eﬃ-
cacious in reducing depressive symptoms for patients
with recurrent depression suﬀering from a current
depressive episode. These results are in line with pre-
vious studies including one randomized, controlled
[Barnhofer et al. 2009 (n=28)], one controlled but not
randomized study [Kingston et al. 2007 (n=19)] and
three uncontrolled studies with a range of 13 to 79
participants (Finucane & Mercer, 2006; Kenny &
Williams, 2007 ; Eisendrath et al. 2008). These studies
showed that patients with current depressive symp-
toms might also beneﬁt from MBCT. Note that the
eﬀect sizes found in our study were smaller than in the
study by, for example, Barnhofer et al. (2009). One
explanation for the reduced eﬀect sizes study might be
the inclusion of patients with recent meditation ex-
perience, since this was shown to be a moderating
variable.
The fact that recent meditation experience was
shown to moderate the level of depressive symptoms
supports the idea that the meditation component plays
a key role in the eﬀects of MBCT but this has yet to be
proven (Williams et al. 2010).
Additional analyses and ﬁgures, especially Fig. 3,
illustrate that not only more patients improved, but
also fewer patients deteriorated in the MBCT con-
dition compared with TAU alone. This is congruent
with the prophylactic results of MBCT for depression
shown in previous studies (e.g. Ma & Teasdale, 2004 ;
Kuyken et al. 2008).
Our ﬁnding that patients without a current
depressive episode also showed reduced levels of de-
pressive symptoms is encouraging, considering the
clinical relevance of residual symptoms in the predic-
tion of relapse and recurrence of depression. Kennedy
et al. (2004) showed that subsyndrome levels of
depression are common and persistent after severe
episodes of depression. Residual depressive symp-
toms have been repeatedly shown as a predictor of
depressive relapse (e.g. Paykel et al. 1995 ; Rush et al.
2006 ; Hardeveld et al. 2010). This may contribute to the
eﬃcacy of MBCT preventing relapse.
The exploratory mediation analysis lends valuable
insights towards a better understanding of the
working mechanism of MBCT. Congruent with our
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hypotheses, it seems that the eﬃcacy of MBCT com-
pared with TAU in reducing post-measurement
levels of depression is mediated by a decrease in
worry, rumination and an increase in the mindfulness
skill ‘accept without judgement ’. Our results are
in line with the ﬁndings of Kuyken et al. (2010), who
showed that 1-year follow-up levels of depression
were mediated by mindfulness skills and self-
compassion. Additionally, the relationship between
cognitive reactivity and levels of depression was
moderated by change in self-compassion during
MBCT, suggesting that mindfulness training changes
the way one relates towards vulnerability for de-
pression. In addition, we found a negative relationship
between rumination and mindfulness skill acceptance,
which might implicate that acceptance decreases
the space for ruminative thoughts as suggested by
the designers of MBCT (Teasdale et al. 1995). Based
on our results, further questions can be generated,
such as the relationship in time between mindfulness
skill ‘accept without judgement ’, worry and rumi-
nation. However, these results must be interpreted
with care. As a result of the cross-sectional nature of
the ﬁndings, no ﬁrm conclusions can be made in terms
of causality (Kraemer et al. 2002 ; Kazdin, 2007). For
that purpose, future studies should use designs with
repeated assessments, for example, a midpoint as-
sessment at session 4.
Although this study provides several important
ﬁndings, there are a number of limitations to be con-
sidered. The design of this study was a pragmatic,
randomized, controlled trial. There might be a nega-
tive eﬀect as a result of randomization in the TAU
condition instead of MBCT, resulting in higher post-
measurement symptom levels in the TAU condition.
Based on the results of this trial, we do not know how
MBCT compares with alternative active treatment
conditions for recurrent depression, such as cognitive
behavioural therapy to prevent relapse (Bockting et al.
2005). Also, the inﬂuence of peer support cannot be
ruled out, since the TAU condition was not group
based. Furthermore, the results are limited to direct
post-measurement results, although it is also im-
portant to investigate whether currently depressed
patients also beneﬁt in the long term. As most of
the patients were self-referred, the results of the
study may have been inﬂuenced by selection bias.
Participants of this study might have been better
informed and more motivated compared with other
patients receiving general mental health care. On the
other hand, inclusion was not restricted to patients
without antidepressant medication, previous cogni-
tive behaviour therapy and/or meditation experience.
In this regard, our study population was more rep-
resentative of routine clinical practice than some of the
previous studies (Teasdale et al. 2000; Ma & Teasdale,
2004).
Conclusions
The greatest merit of this study is that it shows that
MBCT is also eﬃcacious in recurrent depressive
patients with a current depressive episode. The study
also gives some directions toward a better under-
standing of the mechanisms of action of MBCT.
However, the exploratory nature of this justiﬁes fur-
ther investigation.
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